Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Prostatic Neoplasms 1Pitfalls of PET Scan on Pediattic 1Parkinson Disease 1Osteosarcoma 1Neoplasm Metastasis 1Mouth Neoplasms 1Intraabdominal Infections 1Glioma 1Colorectal Neoplasms 1Carcinoma, Neuroendocrine 1Cancer Patients Referred to do PET/CT Study 1

Interventions

Cyclophosphamide 4trastuzumab deruxtecan 3fludarabine 3Standard of Care 3Injections 3Cisplatin 3Bevacizumab 3toripalimab 2sacituzumab govitecan 2pembrolizumab 2fludarabine phosphate 2Specimen Handling 2Radiosurgery 2Pemetrexed 2Palliative Care 2Gemcitabine 2Fulvestrant 2Fluorouracil 2Docetaxel 2130-nm albumin-bound paclitaxel 2zimberelimab 1vedolizumab 1tislelizumab 1sintilimab 1lobaplatin 1lenvatinib 1ivosidenib 1irinotecan sucrosofate 1exemestane 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasm Metastasis × Positron Emission Tomography Computed Tomography × Clear all
NCT06055764 2023-09-28

Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

Assiut University

Not yet recruiting
73 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡